These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 19450072)
1. Analysis of national annual variation in total patient out-of-pocket Medicare Part D stand-alone prescription drug plan costs from 2007 to 2008. Walberg MP; Patel RA; Amaral MM J Med Econ; 2008; 11(4):625-37. PubMed ID: 19450072 [TBL] [Abstract][Full Text] [Related]
2. National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US. Kim MH; Lin J; Kreilick C Adv Ther; 2009 Aug; 26(8):784-94. PubMed ID: 19690820 [TBL] [Abstract][Full Text] [Related]
3. Cost minimization of medicare part D prescription drug plan expenditures. Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958 [TBL] [Abstract][Full Text] [Related]
4. Potential opportunity cost of neglecting to annually reassess Medicare Part D standalone prescription drug plan offerings: the price of contentment? Walberg MP; Patel RA J Am Pharm Assoc (2003); 2009; 49(6):777-82. PubMed ID: 19926558 [TBL] [Abstract][Full Text] [Related]
5. Why using current medications to select a medicare Part D plan may lead to higher out-of-pocket payments. Domino ME; Stearns SC; Norton EC; Yeh WS Med Care Res Rev; 2008 Feb; 65(1):114-26. PubMed ID: 17942795 [TBL] [Abstract][Full Text] [Related]
6. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008. Cheng LI; Rascati KL Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663 [TBL] [Abstract][Full Text] [Related]
7. Beneficiary price sensitivity in the Medicare prescription drug plan market. Frakt AB; Pizer SD Health Econ; 2010 Jan; 19(1):88-100. PubMed ID: 19191252 [TBL] [Abstract][Full Text] [Related]
8. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis. Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722 [TBL] [Abstract][Full Text] [Related]
9. Variation in estimated Medicare prescription drug plan costs and affordability for beneficiaries living in different states. Davis MM; Patel MS; Halasyamani LK J Gen Intern Med; 2007 Feb; 22(2):257-63. PubMed ID: 17356996 [TBL] [Abstract][Full Text] [Related]
10. The Medicare Part D doughnut hole: effect on pharmacy utilization. Sun SX; Lee KY Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394 [TBL] [Abstract][Full Text] [Related]
11. The impact of Medicare Part D on prescription drug use by the elderly. Lichtenberg FR; Sun SX Health Aff (Millwood); 2007; 26(6):1735-44. PubMed ID: 17978393 [TBL] [Abstract][Full Text] [Related]
12. Out-of-pocket pharmacy expenditures for veterans under medicare part D. Rupper RW; Bair BD; Sauer BC; Nebeker JR; Shinogle J; Samore M Med Care; 2007 Oct; 45(10 Supl 2):S77-80. PubMed ID: 17909387 [TBL] [Abstract][Full Text] [Related]
13. The use of disease-modifying agents among multiple sclerosis patients enrolled in medicare from 1995 to 2002 and the impact of medicare part D: analysis of claims data from the medicare current beneficiary survey. Lundy J; Craig BM Clin Ther; 2006 Jan; 28(1):140-5. PubMed ID: 16490588 [TBL] [Abstract][Full Text] [Related]
14. Trends in out-of-pocket healthcare costs among older community-dwelling Medicare beneficiaries. Riley GF Am J Manag Care; 2008 Oct; 14(10):692-6. PubMed ID: 18837647 [TBL] [Abstract][Full Text] [Related]
15. Medicare Part D formulary coverage since program inception: are beneficiaries choosing wisely? Jackson EA; Axelsen KJ Am J Manag Care; 2008 Nov; 14(11 Suppl):SP29-35. PubMed ID: 18991478 [TBL] [Abstract][Full Text] [Related]
16. Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? Shrank WH; Joseph GJ; Choudhry NK; Young HN; Ettner SL; Glassman P; Asch SM; Kravitz RL Am J Manag Care; 2006 Sep; 12(9):545-51. PubMed ID: 16961443 [TBL] [Abstract][Full Text] [Related]
17. Savings from drug discount cards: relief for Medicare beneficiaries? Cubanski J; Frank RG; Epstein AM Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-198-209. PubMed ID: 15451980 [TBL] [Abstract][Full Text] [Related]
18. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis. Polinski JM; Mohr PE; Johnson L Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704 [TBL] [Abstract][Full Text] [Related]
19. Potential impact of pharmacist interventions to reduce cost for Medicare Part D beneficiaries. Thatcher EE; Vanwert EM; Erickson SR J Pharm Pract; 2013 Jun; 26(3):248-52. PubMed ID: 23178417 [TBL] [Abstract][Full Text] [Related]
20. Should healthy Medicare beneficiaries postpone enrollment in Medicare Part D? Atherly A; Dowd B Health Econ; 2009 Aug; 18(8):921-31. PubMed ID: 18972327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]